These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8429843)

  • 1. Sustained focal effects of low-dose intramuscular succinylcholine.
    Walker FO; Scott GE; Butterworth J
    Muscle Nerve; 1993 Feb; 16(2):181-7. PubMed ID: 8429843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial neurophysiological studies of intramuscular botulinum-A toxin in humans.
    Hamjian JA; Walker FO
    Muscle Nerve; 1994 Dec; 17(12):1385-92. PubMed ID: 7969239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve stimulation boosts botulinum toxin action in spasticity.
    Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
    Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans.
    Eleopra R; Tugnoli V; De Grandis D
    Mov Disord; 1997 Jan; 12(1):89-94. PubMed ID: 8990059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short-term electrical stimulation before and after botulinum toxin injection.
    Santus G; Faletti S; Bordanzi I; Pirali F; De Grandis D
    J Rehabil Med; 2011 Apr; 43(5):420-3. PubMed ID: 21448556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachyphylaxis and phase II block development during infusion of succinylcholine in children.
    DeCook TH; Goudsouzian NG
    Anesth Analg; 1980 Sep; 59(9):639-43. PubMed ID: 7191220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of botulinum toxin type A injection on compound muscle action potential in an in vivo rat model.
    Cichon JV; McCaffrey TV; Litchy WJ; Knops JL
    Laryngoscope; 1995 Feb; 105(2):144-8. PubMed ID: 8544593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrodiagnostic tests in the detection of malignant hyperthermia.
    Eng GD; Becker MJ; Muldoon SM
    Muscle Nerve; 1984 Oct; 7(8):618-25. PubMed ID: 6543907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test.
    Cordivari C; Misra VP; Vincent A; Catania S; Bhatia KP; Lees AJ
    Mov Disord; 2006 Oct; 21(10):1737-41. PubMed ID: 16874756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the size of the compound muscle and sensory nerve action potentials recorded from the foot in distal axonopathy.
    Wee AS; Morgan WR; Truitt NR
    Electromyogr Clin Neurophysiol; 2005; 45(3):135-8. PubMed ID: 15981683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals.
    Mukai Y; Shimatani Y; Sako W; Asanuma K; Nodera H; Sakamoto T; Izumi Y; Kohda T; Kozaki S; Kaji R
    Toxicon; 2014 Apr; 81():32-6. PubMed ID: 24495439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable innervation of the intrinsic foot muscles. An electrophysiological study.
    Linden D; Glocker FX; Berlit P
    Electromyogr Clin Neurophysiol; 1996; 36(7):399-403. PubMed ID: 8957164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EBD test--a clinical test for the detection of antibodies to botulinum toxin type A.
    Kessler KR; Benecke R
    Mov Disord; 1997 Jan; 12(1):95-9. PubMed ID: 8990060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensor digitorum brevis test and resistance to botulinum toxin type A.
    Gordon PH; Gooch CL; Greene PE
    Muscle Nerve; 2002 Dec; 26(6):828-31. PubMed ID: 12451609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report.
    Hefter H; Beek J; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34203875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuromuscular blocking action of suxamethonium following intravenous and intramuscular administration.
    Schuh FT
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):399-403. PubMed ID: 7141759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle electromechanical correlations during succinylcholine infusion.
    Donati F; Bevan DR
    Anesth Analg; 1984 Oct; 63(10):891-4. PubMed ID: 6486487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound muscle action potentials during repetitive nerve stimulation.
    Asawa T; Shindo M; Momoi H
    Muscle Nerve; 2004 May; 29(5):724-8. PubMed ID: 15116378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced potency after refrigerated storage of botulitum toxin A: human extensor digitorum brevis muscle study.
    Paik NJ; Seo K; Eun HC
    Mov Disord; 2006 Oct; 21(10):1759-63. PubMed ID: 16856132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.